Lung Cancer

Patients with lung cancer whose depression symptoms became more severe after diagnosis had significantly shorter survival than patients with stagnant or improved symptoms, according to study results published in Psychosomatic Medicine.

People with a smoking history who quit, especially at younger ages, avoid much of the excess risk for dying of cancer associated with continued smoking, according to a prospective study published in JAMA Oncology.

Since the start of the COVID-19 pandemic, many patients have not received preventive care, and “it is vital that they get caught up now,” the chair of the U.S. Preventive Services Task Force told Healio Primary Care.

Karen L. Kelly, MD, has been appointed CEO of International Association for the Study of Lung Cancer.

The FDA cleared an investigational new drug application for P-MUC1C-ALLO1, a chimeric antigen receptor T-cell therapy designed to treat adults with locally advanced or metastatic epithelial-derived solid tumors.

A select group of people who spend their day jobs fighting cancer — as surgical oncologists, radiation epidemiologists, or working in radiobiology and bionanotechnology — had a unique opportunity to lend their expertise to NASA.

Healio presents highlights from the virtual CHEST Annual Meeting, which was held Oct. 17 to 20.

In this video, Charu Aggarwal, MD, MPH, discusses presentations in both non-small cell and small cell lung cancer from Chemotherapy Foundation Symposium.

Stereotactic ablative radiotherapy appeared as effective as surgery among patients with operable early-stage non-small cell lung cancer, according to results published in The Lancet Oncology.

In this video, Julie A. Barta, MD, pulmonologist and assistant professor at Thomas Jefferson University Hospitals, spoke with Healio about takeaways for oncologists from CHEST 2021.